Related Experiment Video
Updated: Jun 16, 2026

Studies of Chaperone-Cochaperone Interactions using Homogenous Bead-Based Assay
Published on: July 21, 2021
Heat shock proteins: therapeutic drug targets for chronic neurodegeneration?
M U Sajjad1, B Samson, A Wyttenbach
1Southampton Neuroscience Group, School of Biological Sciences, University of Southampton, Boldrewood Campus, Basset Crescent East, Southampton SO16 7PX, UK.
Abstract:
Intra- and extracellular protein misfolding and aggregation is likely to contribute to a number of age-related central nervous system diseases ("proteinopathies"). Therefore, molecular chaperones, such as heat shock proteins (HSPs), that regulate protein folding, misfolding and adaption to cellular stress are emerging as therapeutic targets. Here we review the current knowledge of HSP-modulating drugs and discuss the opportunities and difficulties of their therapeutic use to treat proteinopathies such as Alzheimer's- and Parkinson's disease, the polyglutamine- and prion disorders and Amyotrophic Lateral Sclerosis.
Related Concept Videos
Bacterial Protein Maturation
Molecular Chaperones and Protein Folding
The...
Alzheimer's Disease: Treatment
Other Stress Responses in Bacteria

